Skip to content

IMPROVEMENT IN PAIN CONTROL AND NUMBNESS FOLLOWING FACIAL FRACTURES WITH THE USE OF MELATONIN TABLETS

â??EFFECTS OF MELATONIN ON POSTOPERATIVE PAIN AND SENSORY RECOVERY FOLLOWING ZYGOMATICOMAXILLARY COMPLEX FRACTURES - A RANDOMIZED CONTROLLED TRIALâ??

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/043630
Enrollment
64
Registered
2022-07-01
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R69- Illness, unspecified Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: MELATONIN TABLET AND IV ANALGESIC: ORAL TABLET ONCE DAILY AT NIGHT FOR 15 DAYS/ANALGESIC , IV - PARACETAMOL 1G THRICE DAILY FOR 5 DAYS Control Intervention1: IV ANALGESIC: IV-PARACETAMO

Sponsors

self fundedNo sponsors
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with zygomaticomaxillary complex fractures that involve infraorbital foramen. 2. Both unilateral and bilateral fractures. 3. Both male and female. 4. Age above 18 years. 5. Patients who are conscious are only included in the study

Exclusion criteria

Exclusion criteria: 1. Undisplaced zygomticomaxillary complex fractures that does not involve the infra-orbital foramen. 2. Patients aged below 18 yea rs. 3. Patients who cannot take oral tablets due to any medical reasons. 4. Fractures involving the mandible. 5. Pregnant women. 6. Patients who are on blood thinners, antianxiety drugs, nifidipine, diabetic medications.

Design outcomes

Primary

MeasureTime frame
PAIN,SENSORY RECOVERYTimepoint: PAIN AT IMMEDIATE POSTOP,POSTOP DAY1,2,3 ANS 7 SENSORY RECOVERY AT POSTOP DAY7,1ST AND 3RD MONTH POSTOP.

Secondary

MeasureTime frame
additional analgesic usedTimepoint: postoperative day 0 to 7

Countries

India

Contacts

Public ContactDRPAVITHRAN

SRI RAMACHANDRA INSTITUTE OF HIGHER EDUCATION AND RESEARCH

drpavithran96@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026